• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴喉气管侵犯的非分泌型甲状腺髓样癌:一例报告并文献复习

Non-secretory medullary thyroid carcinoma with laryngotracheal invasion: a case report and review of the literature.

作者信息

Alsalamah Shmokh, Althunayan Thamer, Alaraifi Abdulaziz, Alessa Mohammed

机构信息

College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.

出版信息

AME Case Rep. 2024 Aug 2;8:87. doi: 10.21037/acr-24-45. eCollection 2024.

DOI:10.21037/acr-24-45
PMID:39380863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459395/
Abstract

BACKGROUND

Medullary thyroid carcinoma (MTC) is a rare and aggressive type of thyroid cancer. Patients with this condition typically manifest palpable neck swelling and compressive symptoms. Biochemical evaluation and neck ultrasound play vital roles in diagnosis. The management options differ based on the extent of the disease.

CASE DESCRIPTION

This paper describes a 47-year-old male patient diagnosed with MTC invading the trachea and larynx. He presented with a 5 cm × 5 cm hard thyromegaly on the right side with right-sided level IV lymphadenopathy, measuring approximately 2 cm. He underwent total thyroidectomy, total laryngectomy, and bilateral neck dissection. Postoperatively, the patient developed a neck abscess and pharyngocutaneous fistula (PCF), which was managed surgically and had a satisfactory outcome. After 128 days of inpatient care, he was discharged in a stable condition with resolution of complications and had no evidence of local recurrence during the 6-month follow-up.

CONCLUSIONS

MTC is a rare type of thyroid neoplasia that can manifest with various symptoms resulting from either the primary lesion or secondary invasion. Surgery remains the mainstay of treatment, however, there are limited options and no approved adjuvant therapies for patients with disseminated MTC. Complications that arise after total thyroidectomy and laryngectomy can be noteworthy and demand careful surveillance and immediate treatment to prevent further deterioration.

摘要

背景

甲状腺髓样癌(MTC)是一种罕见且侵袭性强的甲状腺癌。患有这种疾病的患者通常表现为可触及的颈部肿胀和压迫症状。生化评估和颈部超声在诊断中起着至关重要的作用。治疗方案因疾病范围而异。

病例描述

本文描述了一名47岁男性患者,诊断为MTC侵犯气管和喉。他右侧有一个5厘米×5厘米的硬甲状腺肿大,右侧IV区淋巴结肿大,大小约2厘米。他接受了全甲状腺切除术、全喉切除术和双侧颈部清扫术。术后,患者出现颈部脓肿和咽皮肤瘘(PCF),通过手术治疗,效果满意。经过128天的住院治疗,他病情稳定出院,并发症得到解决,在6个月的随访期间没有局部复发的迹象。

结论

MTC是一种罕见的甲状腺肿瘤,可因原发性病变或继发性侵犯而表现出各种症状。手术仍然是主要的治疗方法,然而,对于播散性MTC患者,选择有限且没有批准的辅助治疗方法。全甲状腺切除术和喉切除术后出现的并发症可能值得关注,需要仔细监测并立即治疗以防止病情进一步恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243c/11459395/25c430f6c959/acr-08-24-45-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243c/11459395/b5b5c4733b3f/acr-08-24-45-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243c/11459395/3f075e4cbf6b/acr-08-24-45-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243c/11459395/25c430f6c959/acr-08-24-45-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243c/11459395/b5b5c4733b3f/acr-08-24-45-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243c/11459395/3f075e4cbf6b/acr-08-24-45-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/243c/11459395/25c430f6c959/acr-08-24-45-f3.jpg

相似文献

1
Non-secretory medullary thyroid carcinoma with laryngotracheal invasion: a case report and review of the literature.伴喉气管侵犯的非分泌型甲状腺髓样癌:一例报告并文献复习
AME Case Rep. 2024 Aug 2;8:87. doi: 10.21037/acr-24-45. eCollection 2024.
2
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
3
Intermixed medullary and papillary thyroid cancer in a patient with renal cell carcinoma.一名肾细胞癌患者合并有髓样和乳头状甲状腺癌。
Endocrinol Diabetes Metab Case Rep. 2020 Jun 4;2020. doi: 10.1530/EDM-20-0025.
4
A Malignant Duo: Mixed Medullary and Follicular Variant Papillary Thyroid Cancer.恶性组合:髓样与滤泡样变异型混合性甲状腺乳头状癌
Cureus. 2024 Aug 19;16(8):e67231. doi: 10.7759/cureus.67231. eCollection 2024 Aug.
5
Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.散发性甲状腺髓样癌的手术治疗策略:我们的经验
G Chir. 2012 Nov-Dec;33(11-12):395-9.
6
Gastropharyngeal Anastomotic Leak in Medullary Thyroid Carcinoma Following Initiation of a Tyrosine Kinase Inhibitor: A Case Report of an Unusual Side Effect of Cabozantinib.甲状腺髓样癌患者在开始使用酪氨酸激酶抑制剂后发生胃咽吻合口漏:卡博替尼罕见副作用的病例报告
Ann Otol Rhinol Laryngol. 2020 Jul;129(7):657-661. doi: 10.1177/0003489420902161. Epub 2020 Feb 10.
7
Surgical management of thyroid cancer invading the airway.侵犯气道的甲状腺癌的手术治疗
Ann Surg Oncol. 1997 Jul-Aug;4(5):403-8. doi: 10.1007/BF02305553.
8
Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.经单侧耳后入路机器人辅助全甲状腺切除术并改良根治性颈清扫术
Ann Surg Oncol. 2014 Nov;21(12):3872-5. doi: 10.1245/s10434-014-3896-y. Epub 2014 Sep 17.
9
The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature.分子检测在甲状腺髓样癌诊断中的作用:一例嗜酸细胞性甲状腺髓样癌病例报告及文献复习。
Am J Otolaryngol. 2020 Jan-Feb;41(1):102312. doi: 10.1016/j.amjoto.2019.102312. Epub 2019 Nov 11.
10
Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.经腋后(TARA)入路机器人辅助施行 Sistrunk 手术、甲状腺全切除术和颈淋巴结清扫术治疗甲状舌管囊肿和甲状腺起源的乳头状癌
Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16.

本文引用的文献

1
The Evolving Treatment Landscape of Medullary Thyroid Cancer.甲状腺髓样癌的治疗进展。
Curr Treat Options Oncol. 2023 Dec;24(12):1815-1832. doi: 10.1007/s11864-023-01145-5. Epub 2023 Nov 18.
2
A review of pharyngocutaneous fistula management in head and neck malignancies.头颈部恶性肿瘤咽皮瘘管理的综述。
Ann Palliat Med. 2023 Sep;12(5):1081-1088. doi: 10.21037/apm-22-1475. Epub 2023 Sep 7.
3
Preoperative neck ultrasound combined with pathological data can significantly impact the outcome of medullary thyroid carcinoma.
术前颈部超声联合病理数据可显著影响甲状腺髓样癌的预后。
Endocr J. 2023 Nov 28;70(11):1061-1067. doi: 10.1507/endocrj.EJ23-0273. Epub 2023 Sep 9.
4
Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review.经口咽入路重建方法以降低全喉切除术后咽瘘风险的研究进展:系统评价。
Adv Ther. 2023 Sep;40(9):3681-3696. doi: 10.1007/s12325-023-02561-7. Epub 2023 Jul 12.
5
Prevalence and significance of indeterminate calcitonin values in patients with thyroid nodules: A systematic review and meta-analysis.甲状腺结节患者降钙素值不确定的患病率和意义:系统评价和荟萃分析。
Rev Endocr Metab Disord. 2023 Aug;24(4):685-694. doi: 10.1007/s11154-023-09811-7. Epub 2023 May 31.
6
The Incidence and the Risk Factors for Pharyngocutaneous Fistula following Primary and Salvage Total Laryngectomy.初次及挽救性全喉切除术后咽瘘的发生率及危险因素
Cancers (Basel). 2023 Apr 12;15(8):2246. doi: 10.3390/cancers15082246.
7
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?甲状腺髓样癌诊断与管理的最新进展:近年来有哪些变化?
Cancers (Basel). 2022 Jul 27;14(15):3643. doi: 10.3390/cancers14153643.
8
Predictive Value of Risk Factors for Pharyngocutaneous Fistula After Total Laryngectomy.全喉切除术后咽皮肤瘘危险因素的预测价值
Laryngoscope. 2023 Apr;133(4):742-754. doi: 10.1002/lary.30278. Epub 2022 Jun 29.
9
"Triple-negative" non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease.“三阴性”非分泌型甲状腺髓样癌:一种罕见疾病中的不常见病理表现
Arch Med Sci. 2022 Apr 20;18(3):825-828. doi: 10.5114/aoms/147431. eCollection 2022.
10
Thyroidectomy with and without laryngectomy: Differences in post-operative hypocalcemia and management.甲状腺切除术伴或不伴喉切除术:术后低钙血症及其处理的差异。
Am J Otolaryngol. 2022 Mar-Apr;43(2):103316. doi: 10.1016/j.amjoto.2021.103316. Epub 2021 Dec 15.